I now have rich content from all chapters. Let me compile the comprehensive teaching summary.Here is your complete Harrison's hematology master guide covering all the chapters you requested:
Harrison's Hematology - Section 9 Master Guide
Chapters 65, 66, 67, 68, 69 & Chapter 70 (Lymph Node/Spleen)
CHAPTER 65 - Interpreting Peripheral Blood Smears
Harrison's Principles of Internal Medicine, 22E
The Skill Every Internist Must Master
The peripheral blood smear is one of the most informative things a doctor can do. Automated counters are not a substitute - you must know the patient's clinical history, family history, and physical findings to interpret it properly.
Where to look: The feathered edge - where red cells lie in a single layer, barely touching, not overlapping.
Order of examination: Smallest to largest: Platelets → Red cells → White cells
PLATELETS (examine first)
- Count 5-6 fields under oil immersion (×100), average per field, multiply by 20,000 = rough platelet count
- Normal: 1-2 μm diameter, blue granulated appearance; ~1 platelet per 20 red cells
- Large platelets = rapid turnover (young platelets are bigger); OR rare inherited syndromes
- Low count with no large platelets = marrow production problem
- Platelet clumping = EDTA-related artifact causing falsely low automated count
- Neutrophil fragmentation = falsely elevated automated platelet count
- Absent platelet granules = gray platelet syndrome (rare congenital) or marrow disease
- Elevated count = myeloproliferative disorder OR reactive (systemic inflammation)
RED CELLS (examine second)
Size reference: Compare RBC to small lymphocyte nucleus - both normally ~8 μm wide.
| Finding | Significance |
|---|
| Microcytosis | RBC smaller than lymphocyte nucleus |
| Macrocytosis | RBC larger than lymphocyte nucleus (also more oval = macro-ovalocytes) |
| Anisocytosis | Wide variation in size |
| Poikilocytosis | Wide variation in shape |
| RDW (red cell distribution width) | Normal 11-14%; rises to 15-18% with morphologic anisocytosis |
Key RDW formula: RDW = (SD of MCV ÷ mean MCV) × 100
Clinical use of RDW in microcytic anemia:
- Iron deficiency: RDW elevated (mixed-size cells, early iron-deficient cells are small)
- Thalassemia: RDW usually normal (uniformly small cells)
Specific RBC Morphology
| Abnormal Cell | Diagnosis/Significance |
|---|
| Burr cells (echinocytes) | Uremia, artifact |
| Elliptocytes | Hereditary elliptocytosis |
| Howell-Jolly bodies | Asplenia, splenic dysfunction |
| Hypochromia/microcytosis | Iron deficiency, thalassemia |
| Macro-ovalocytes | B12/folate deficiency (megaloblastic anemia) |
| Nucleated RBCs | Myelophthisic process, severe hemolysis, marrow infiltration |
| Schistocytes | Microangiopathic hemolytic anemia (TTP, HUS, DIC, mechanical heart valve) |
| Sickle cells | Sickle cell disease |
| Spherocytes | Hereditary spherocytosis, autoimmune hemolytic anemia |
| Target cells | Liver disease, thalassemia, hemoglobin C disease |
| Tear-drop cells (dacrocytes) | Marrow infiltration (myelophthisic anemia) |
| Acanthocytes | Abetalipoproteinemia, severe liver disease |
| Basophilic stippling | Lead poisoning, thalassemia, sideroblastic anemia |
| Rouleaux | Hypergammaglobulinemia, multiple myeloma |
WHITE CELLS (examine third)
- Normal differential: Neutrophils 50-70%, Lymphocytes 20-40%, Monocytes 2-8%
- Left shift = increased band forms (immature neutrophils) - sign of acute infection/inflammation
- Hypersegmented neutrophils (>5 lobes) = B12/folate deficiency
- Toxic granulation + Döhle bodies = severe bacterial infection, sepsis
- Pelger-Hüet anomaly = bilobed neutrophils; genetic (LBR mutation) or acquired (MDS)
- Auer rods = pathognomonic for AML (myeloid blasts)
- Atypical lymphocytes = EBV (infectious mononucleosis), CMV, viral infections
CHAPTER 66 - Anemia and Polycythemia
Epidemiology
Anemia affects almost 2 billion people worldwide - one of the most common medical problems.
Normal Red Cell Production
- Hematopoietic stem cell → regulated by transcription factors GATA-1 and FOG-1 for erythroid/megakaryocytic lineage
- EPO (erythropoietin) = primary regulatory hormone from kidney; absence → apoptosis of erythroid progenitors
- First morphologically recognizable erythroid precursor = pronormoblast → 4-5 divisions → 16-32 mature RBCs
- Normal RBC: 8 μm, anucleate, biconcave disc; survives 100-120 days
- Daily replacement: 0.8-1% of all circulating RBCs
EPO production is regulated by tissue oxygen tension (kidney senses hypoxia → increases EPO).
Classification of Anemia (3 mechanisms)
1. Hypoproliferative Anemia (most common - 75% of all anemias)
- Inadequate EPO production OR marrow unable to respond
- Causes: Iron deficiency, inflammation (anemia of chronic disease), renal disease (low EPO), marrow suppression
2. Maturation Defect Anemia
- Nuclear maturation defect (DNA synthesis impaired): B12/folate deficiency → megaloblastic anemia, macrocytosis, hypersegmented neutrophils
- Cytoplasmic maturation defect (hemoglobin synthesis impaired): Iron deficiency, thalassemia → microcytic, hypochromic
3. Blood Loss / Hemolysis
- Blood loss or accelerated destruction → reticulocytosis (marrow responding)
- Intravascular hemolysis: hemoglobinuria, low haptoglobin, elevated LDH
- Extravascular hemolysis: spleen destroys RBCs, elevated indirect bilirubin
Key Laboratory Tests
| Test | Normal Values | Clinical Use |
|---|
| Serum iron | 9-27 μmol/L (50-150 μg/dL) | Iron availability |
| TIBC (total iron binding capacity) | 54-64 μmol/L (300-360 μg/dL) | Surrogate for transferrin |
| Transferrin saturation | 25-50% | (Serum iron ÷ TIBC) × 100 |
| Serum ferritin | Males ~100 μg/L; Females ~30 μg/L | Iron stores; also acute phase reactant |
| Ferritin <30 μg/L | - | Iron stores depleted |
| Ferritin >200 μg/L | - | At least some stores present |
| Reticulocyte count | 1-2% | Marrow response to anemia |
Specific Causes
Iron Deficiency:
- Most common nutritional deficiency worldwide
- Most common in premenopausal women (menstrual losses)
- Classic finding: microcytic, hypochromic anemia
- Early iron deficiency may not show microcytosis
- Low ferritin + low transferrin saturation
Vitamin B12 Deficiency:
- Required for RBC DNA synthesis → deficiency = impaired DNA synthesis
- Classic finding: macrocytosis + hypersegmented neutrophils + remarkably hypercellular marrow with large abnormal precursors
- Neurologic manifestations (subacute combined degeneration)
Folate Deficiency:
- Same hematologic picture as B12 (grouped as megaloblastic anemia)
- No neurological manifestations
- Rare in countries supplementing flour with folate
- See in poor diet, severe malabsorption
Copper Deficiency:
- Associated with neurologic disease AND neutropenia
Vitamin C Deficiency:
- Severe anemia + clinical findings of scurvy
Marrow Replacement (Myelophthisic Anemia):
- Infections (histoplasmosis, TB) or neoplasms (prostate cancer metastases, multiple myeloma) crowd out hematopoietic elements
- Blood smear: nucleated RBCs + tear-drop cells + immature WBCs = leukoerythroblastic picture
- Mandates bone marrow biopsy
Renal Anemia:
- Kidney = primary source of EPO → renal disease → reduced EPO → hypoproliferative anemia
- Normocytic, normochromic; low reticulocyte count
Polycythemia
- Relative polycythemia = decreased plasma volume (dehydration, "stress polycythemia")
- Absolute polycythemia = increased RBC mass
- Primary: Polycythemia vera (JAK2 V617F mutation; low EPO)
- Secondary: High EPO - appropriate (altitude, COPD, sleep apnea) or inappropriate (renal cell carcinoma, hepatocellular carcinoma producing EPO)
CHAPTER 67 - Disorders of Granulocytes and Monocytes
Granulopoiesis
- Myeloid stem cell → committed progenitor → myeloblast → promyelocyte → myelocyte → metamyelocyte → band → neutrophil
- G-CSF (granulocyte colony-stimulating factor) is the key cytokine
- Bone marrow storage pool = 10-15 times the circulating neutrophil mass; released in infection/stress
Neutrophil Function
- Margination - neutrophils loosely adhere to vascular endothelium (selectins)
- Rolling - along endothelium via selectins
- Adhesion - firm adhesion via integrins (LFA-1/Mac-1 binding ICAM-1)
- Diapedesis - migration through vessel wall
- Chemotaxis - movement toward bacteria (fMLF, C5a, IL-8, leukotriene B4)
- Phagocytosis - engulf opsonized bacteria (IgG + complement)
- Killing - oxidative burst (NADPH oxidase/NOX2 → superoxide → H2O2 → myeloperoxidase + Cl⁻ → hypochlorous acid/bleach); non-oxidative (defensins, elastase, lysozyme, lactoferrin)
Neutrophil Extracellular Traps (NETs): DNA scaffolds decorated with granule proteins (proteases, antimicrobial peptides) - immobilize invading microorganisms.
After phagocytosis: neutrophils die in 1-4 days in tissues; G-CSF and IFN-γ prolong their life span.
Neutropenia
Definition: ANC (absolute neutrophil count) < 1800/μL
- Mild: 1000-1800/μL
- Moderate: 500-1000/μL
- Severe: <500/μL (risk of serious infection rises sharply)
- Profound: <100/μL (Kostmann's syndrome level)
Hereditary Neutropenias
| Syndrome | Gene | Key Features |
|---|
| Kostmann syndrome | HAX-1 | Neutrophils <100/μL; anti-apoptosis gene mutation; often fatal |
| Severe chronic neutropenia | ELANE (neutrophil elastase) | ANC 300-1500/μL |
| Cyclic hematopoiesis | ELANE | Cyclic neutropenia every ~21 days |
| Cartilage-hair hypoplasia | RMRP | Short stature + neutropenia |
| Shwachman-Diamond syndrome | SBDS | Pancreatic exocrine insufficiency + neutropenia |
| WHIM syndrome | CXCR4 | Warts, hypogammaglobulinemia, infections, myelokathexis |
| Reticular dysgenesis | AK2 | Absence of both myeloid AND lymphoid cells |
Mutations in G-CSF receptor in severe congenital neutropenia are linked to leukemia development.
Felty syndrome: Triad of rheumatoid arthritis + splenomegaly + neutropenia. Antibodies shorten neutrophil life; large granular lymphocytes attack marrow precursors. Splenectomy may help.
Neutrophilia
Causes:
- Infection (most important acute cause) - increased production + marrow release
- Glucocorticoids - mobilize marginated pool from blood vessel walls
- Epinephrine/exercise/stress - demargination (doubles count in minutes)
- Cigarette smoking - mild chronic elevation
- Chronic inflammation
- Myeloproliferative diseases
Leukemoid reaction: WBC ≥30,000-50,000/μL with mature, non-clonal neutrophils (vs leukemia where cells are clonal and often immature).
Neutrophil Function Defects
Chronic Granulomatous Disease (CGD)
- Defect in NADPH oxidase (NOX2) → cannot generate oxidative burst
- X-linked (most common) or autosomal recessive
- Recurrent infections with catalase-positive organisms: Staph aureus, Aspergillus, Serratia, Nocardia, Burkholderia
- Granuloma formation (try to wall off what they can't kill)
- Diagnosis: DHR (dihydrorhodamine) flow cytometry or nitroblue tetrazolium (NBT) test
Leukocyte Adhesion Deficiency (LAD)
- Type I: CD18 (beta-2 integrin) deficiency → neutrophils can't adhere/migrate
- Hallmark: Extremely high WBC count with no pus despite severe infection; delayed umbilical cord separation
- Diagnosis: flow cytometry for CD11b/CD18
Chediak-Higashi Syndrome
- Defect in LYST (lysosomal trafficking regulator) gene
- Giant lysosomes in neutrophils, monocytes, lymphocytes on smear
- Partial albinism + recurrent infections + peripheral neuropathy
- Accelerated phase = HLH-like picture
Myeloperoxidase (MPO) Deficiency
- Most common inherited neutrophil disorder
- Usually asymptomatic; mild susceptibility to Candida especially with diabetes
Eosinophilia and Basophilia
Eosinophilia (>500/μL):
- Allergic diseases (asthma, hay fever, eczema)
- Drug reactions
- Parasitic infections (especially tissue-invasive: Toxocara, Strongyloides, Ascaris)
- Hypereosinophilic syndrome (>1500/μL for >6 months with organ damage)
- Malignancy (Hodgkin lymphoma, T-cell lymphoma)
- Adrenal insufficiency (Addison's - classic boards point)
Basophilia:
- Myeloproliferative disorders (especially CML - basophilia is a hallmark)
- Allergic reactions, hypothyroidism
Monocytes and Macrophages
- Monocytes circulate 1-3 days then enter tissues → become macrophages
- Monocytosis: TB, fungal infections, monocytic leukemia, inflammatory bowel disease, recovery from neutropenia
- Macrophages are central to granuloma formation (TB, sarcoidosis, Crohn's)
CHAPTER 68 - Primary and Secondary Hemophagocytic Lymphohistiocytosis (HLH)
What is HLH?
A highly life-threatening condition of massive, uncontrolled inflammation (hyperinflammation). Primary (genetic) and secondary (acquired) forms exist. All forms share a convergent phenotype - sepsis-like inflammation → multiple organ failure → death if untreated.
- Primary HLH: Mostly children; Mendelian (genetic)
- Secondary HLH: Far more common in adults; triggered by infections, malignancies, autoimmune diseases
Macrophage Activation Syndrome (MAS or MAS-HLH) = HLH triggered by autoimmune conditions (SoJIA, adult-onset Still's disease, SLE)
Primary HLH - Genetic Forms
All primary HLH involves defects in lymphocyte cytotoxicity - cytotoxic T-cells and NK cells cannot effectively kill target cells, leading to prolonged immune activation.
| Gene | Syndrome |
|---|
| PRF1 | FHL2 - Familial HLH type 2 (perforin deficiency - most common) |
| UNC13D | FHL3 |
| STX11 | FHL4 |
| STXBP2 | FHL5 |
| SH2D1A | XLP1 (X-linked lymphoproliferative disease type 1) |
| RAB27A | Griscelli syndrome type 2 |
| LYST | Chediak-Higashi syndrome |
| BIRC4 | XLP2 (inflammasome activation defect) |
Secondary HLH Triggers
- Infection-associated: EBV (most common viral trigger), CMV, HIV, bacteria, parasites, fungi
- Malignancy-associated: T-cell lymphoma, NK-cell lymphoma (most common), B-cell lymphoma
- Autoimmune-associated (MAS): SoJIA, adult-onset Still's disease, SLE, vasculitis
- Transplant-associated: Post-HSCT, post-CAR-T cell therapy
HScore - Diagnostic Scoring
(Probability of HLH based on clinical features - score >169 = >93% probability of HLH)
HLH-2004 Diagnostic Criteria (≥5/8 required)
- Fever ≥38.5°C
- Splenomegaly
- Cytopenias in ≥2 cell lines (Hb <90 g/L; platelets <100×10⁹/L; neutrophils <1×10⁹/L)
- Hypertriglyceridemia (fasting triglycerides ≥3 mmol/L) AND/OR hypofibrinogenemia (fibrinogen ≤1.5 g/L)
- Hemophagocytosis in bone marrow, spleen, or lymph nodes
- Low/absent NK-cell activity
- Ferritin ≥500 μg/L (very high ferritin, often >10,000 is highly suggestive)
- Elevated soluble CD25 (sIL-2 receptor) ≥2400 U/mL
Treatment
- Primary HLH: HLH-94/HLH-2004 protocol (dexamethasone + etoposide); followed by allogeneic HSCT (only cure)
- MAS-HLH: Treat underlying autoimmune disease + cyclosporine + anakinra (IL-1 blockade)
- Secondary HLH (infection-associated): Treat underlying trigger + immunosuppression if needed
Key point: Ferritin >10,000 μg/L has very high specificity for HLH. Extremely high ferritin + fever + splenomegaly + cytopenias = think HLH immediately.
CHAPTER 69 - Bleeding and Thrombosis
Clinical Approach to Bleeding Disorders
The most important predictor of bleeding risk = history of bleeding
Key history questions:
- Spontaneous vs. trauma/surgery-induced bleeding?
- Mucosal bleeding (epistaxis, heavy periods, gum bleeding) = platelet/VWD disorder (primary hemostasis)
- Hemarthroses (joint bleeds) = clotting factor deficiency (factor VIII, IX) = secondary hemostasis
- Family history (inherited vs acquired)
- Medications (aspirin, NSAIDs, anticoagulants, supplements)
ISTH Bleeding Assessment Tool - validated tool to predict inherited bleeding disorders, especially type 1 VWD.
Primary Hemostasis (Platelet Plug Formation)
Step 1 - Vascular injury → subendothelial collagen exposed + endothelin release + vasoconstriction
Step 2 - Platelet adhesion → von Willebrand factor (VWF) bridges collagen to platelet GPIb-IX-V
Step 3 - Platelet activation → shape change, granule release (ADP, TXA2, serotonin)
Step 4 - Platelet aggregation → GPIIb/IIIa binds fibrinogen → platelet-platelet bridges
Disorders of Primary Hemostasis (Platelet Plug)
Defects of Platelet Adhesion:
- Von Willebrand Disease (VWD) - most common inherited bleeding disorder; VWF deficiency/dysfunction
- Bernard-Soulier syndrome - absent/dysfunctional GPIb-IX-V; giant platelets + thrombocytopenia
Defects of Platelet Aggregation:
- Glanzmann's thrombasthenia - absent/dysfunctional GPIIb/IIIa; normal platelet count but no aggregation
- Afibrinogenemia - no fibrinogen to bridge platelets
Defects of Platelet Secretion:
- Decreased cyclooxygenase activity (aspirin, NSAIDs)
- Storage pool diseases (dense granule deficiency)
Secondary Hemostasis (Coagulation Cascade)
Extrinsic pathway: Tissue factor + Factor VII → VIIa → activates X → Xa
Intrinsic pathway: XII → XI → IX → VIIIa + IXa → activates X
Common pathway: Xa + Va → prothrombin (II) → thrombin (IIa) → fibrinogen → fibrin
Coagulation Tests
| Test | Pathway | Factors Detected |
|---|
| PT (prothrombin time)/INR | Extrinsic + common | VII, X, V, II, fibrinogen |
| aPTT (activated partial thromboplastin time) | Intrinsic + common | XII, XI, IX, VIII, X, V, II, fibrinogen |
| Thrombin time | Fibrinogen → fibrin | Fibrinogen, thrombin inhibitors |
| Bleeding time / PFA-100 | Primary hemostasis | Platelet function, VWF |
Important Clotting Factor Disorders
| Disorder | Factor | Key Features |
|---|
| Hemophilia A | Factor VIII | X-linked; hemarthroses; aPTT prolonged, PT normal |
| Hemophilia B (Christmas disease) | Factor IX | X-linked; same clinical picture as A |
| VWD Type 1 | VWF (partial quantitative) | Mucosal bleeding; most common |
| VWD Type 2 | VWF (qualitative) | Subtypes 2A, 2B, 2M, 2N |
| VWD Type 3 | VWF (absent) | Severe; also low factor VIII |
| DIC | Multiple | All factors consumed; elevated D-dimer, low fibrinogen |
Thrombosis
History of thrombosis key points:
- Arterial thrombosis = platelet-rich ("white clot") - often from atherosclerosis, atrial fibrillation
- Venous thrombosis = fibrin-rich ("red clot") - stasis, hypercoagulability
Virchow's Triad (DVT/PE pathophysiology)
- Stasis (immobility, heart failure)
- Endothelial injury (surgery, trauma, indwelling catheters)
- Hypercoagulability (inherited or acquired)
Inherited Thrombophilias
| Condition | Defect | Risk |
|---|
| Factor V Leiden | Resistance to protein C | Most common inherited thrombophilia |
| Prothrombin G20210A | Elevated prothrombin | 2nd most common |
| Protein C deficiency | Reduced anticoagulant | Neonatal purpura fulminans (homozygous) |
| Protein S deficiency | Reduced anticoagulant co-factor | Similar to Protein C deficiency |
| Antithrombin deficiency | Reduced heparin co-factor | Heparin resistance |
| MTHFR mutation | Hyperhomocysteinemia | Weak risk factor |
Acquired Thrombophilias
- Antiphospholipid syndrome (APS): Lupus anticoagulant + anticardiolipin antibodies + anti-β2GP1; paradoxically prolonged aPTT but causes THROMBOSIS; recurrent pregnancy loss
- Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia
- Malignancy: Trousseau syndrome (migratory thrombophlebitis)
- Oral contraceptives, HRT
- Prolonged immobility, pregnancy, obesity
CHAPTER 70 - Enlargement of Lymph Nodes and Spleen
Lymphadenopathy
Epidemiology
-
2/3 of patients with lymphadenopathy in primary care have nonspecific/viral upper respiratory causes
- <1% have malignancy in primary care settings
- In referral settings: 84% benign; 16% malignant (lymphoma or metastatic adenocarcinoma)
- Of benign: 63% nonspecific/reactive; rest = infectious mono, toxoplasmosis, TB most commonly
Normal Nodes (do NOT investigate further)
- Submandibular nodes <1 cm in children/young adults - normal
- Inguinal nodes up to 2 cm in healthy adults - normal
- Soft, flat, non-tender
Clinical Assessment Framework
History:
- Age (children/young adults = benign viral; >50 years = malignancy rises)
- Symptoms: sore throat, cough, fever, night sweats, fatigue, weight loss
- Exposures: pets (cat-scratch disease, toxoplasmosis), sexual history (HIV, syphilis), TB exposure
- Occupation
- Drugs: phenytoin (diphenylhydantoin) causes lymphadenopathy
- Tobacco history + cervical nodes → malignancy must be excluded
Physical exam:
- Localized or generalized (≥3 non-contiguous regions)
- Size, texture (soft/hard/rubbery), tenderness, fluctuance
- Overlying skin changes
- Splenomegaly
- Other organomegaly
Node Characteristics Guide
| Feature | Suggests |
|---|
| Soft, tender, mobile | Reactive/infectious |
| Hard, fixed, non-tender | Malignancy |
| Rubbery, matted | Lymphoma |
| Fluctuant | Abscess, TB lymphadenitis |
| Generalized | Systemic disease (HIV, EBV, SLE, lymphoma) |
| Supraclavicular node (Virchow's node) | Intra-abdominal or thoracic malignancy |
Differential Diagnosis of Lymphadenopathy
Infectious:
- Viral: EBV (mono), CMV, HIV, hepatitis, rubella, adenovirus
- Bacterial: Streptococcal, TB, cat-scratch disease (Bartonella), brucellosis, syphilis
- Fungal: Histoplasmosis, coccidioidomycosis
- Parasitic: Toxoplasmosis
Immunologic:
- SLE, rheumatoid arthritis (Felty), serum sickness, drug reaction (phenytoin, allopurinol, INH)
Malignant:
- Hodgkin lymphoma (Reed-Sternberg cells)
- Non-Hodgkin lymphoma
- Leukemia (CLL, ALL)
- Metastatic carcinoma (breast, lung, melanoma, head/neck)
Other:
- Sarcoidosis
- Castleman disease
- Kikuchi disease (necrotizing lymphadenitis - young Asian women, self-limiting)
- Amyloidosis
When to Biopsy?
- Nodes >2 cm persisting >4-6 weeks without explanation
- Hard, fixed nodes
- Supraclavicular adenopathy (always biopsy - very high malignancy risk)
- Generalized adenopathy with constitutional symptoms ("B symptoms": fever, night sweats, weight loss >10%)
- Progressive growth
- Abnormal CBC or LDH
Splenomegaly
Functions of the Spleen
- Filtration - removes senescent/abnormal RBCs; removes encapsulated bacteria (asplenic patients at risk for overwhelming sepsis from Pneumococcus, Meningococcus, H. influenzae)
- Immune surveillance - T and B cell areas, immunoglobulin production
- Storage - platelets, monocytes
- Hematopoiesis - extramedullary hematopoiesis when marrow fails
Causes of Splenomegaly
Massive splenomegaly (spleen extends beyond umbilicus):
- Chronic myeloid leukemia (CML)
- Myelofibrosis
- Visceral leishmaniasis (kala-azar)
- Malaria (hyperreactive malarial splenomegaly)
- Thalassemia major/intermedia
Moderate:
- Portal hypertension (cirrhosis, schistosomiasis)
- Lymphoma, leukemia
- Storage diseases (Gaucher's, Niemann-Pick)
- Autoimmune hemolytic anemia
Mild:
- Infectious mononucleosis (EBV)
- Bacterial endocarditis
- Viral hepatitis
- Rheumatoid arthritis, SLE
- Systemic infections
Hypersplenism
- Splenomegaly → sequestration and destruction of blood cells
- Pancytopenia (low WBC, RBC, platelets) with hypercellular bone marrow
- Treat underlying cause; splenectomy as last resort
Assessment
- Physical exam: Normally the spleen must enlarge 2-3x before palpable
- Best imaging: ultrasound or CT (spleen >12 cm = splenomegaly)
- Nuclear scan: most sensitive for function
MASTER CLINICAL PEARLS - High-Yield Exam Points
- RDW elevated + microcytosis = iron deficiency; RDW normal + microcytosis = thalassemia
- Auer rods = AML (pathognomonic)
- Hypersegmented neutrophils = B12/folate deficiency
- Pelger-Hüet anomaly = bilobed neutrophils (inherited LBR mutation or acquired in MDS)
- Hemarthroses = factor deficiency (hemophilia); Mucosal bleeding = platelet/VWD problem
- Prolonged aPTT, normal PT = intrinsic pathway defect (hemophilia A/B, VWD, lupus anticoagulant)
- Prolonged PT, normal aPTT = extrinsic pathway (factor VII deficiency, early liver disease, warfarin)
- Both PT + aPTT prolonged = common pathway defect, DIC, severe liver disease, supratherapeutic anticoagulation
- APS = prolonged aPTT but causes CLOTS not bleeding; recurrent pregnancy loss
- Factor V Leiden = most common inherited thrombophilia; activated protein C resistance
- Ferritin >10,000 = think HLH immediately (along with fever, splenomegaly, cytopenias)
- Felty syndrome = RA + splenomegaly + neutropenia
- CGD = recurrent catalase-positive organism infections; NBT test negative (no oxidative burst)
- LAD type I = very high WBC + no pus + delayed cord separation
- Kostmann syndrome = neutrophils <100/μL; HAX-1 mutation; often fatal without G-CSF/HSCT
- Supraclavicular lymphadenopathy = always workup aggressively; highest malignancy risk of any location
- Massive splenomegaly = think CML, myelofibrosis, kala-azar, thalassemia, malaria
- Asplenic patients = at risk for overwhelming sepsis from encapsulated organisms; vaccinate against Pneumococcus, Meningococcus, H. influenzae
- Pronormoblast = first morphologically recognizable erythroid precursor
- EPO from kidney = absence causes apoptosis of erythroid progenitors; renal failure → normocytic anemia
*All content from Harrison's Principles of Internal Medicine, 22nd Edition (2025), McGraw Hill Medical - Chapters 65, 66, 67, 68, 69, and 70.*That is your complete Harrison's hematology master guide. Here is a summary of what was covered from each chapter:
What You Just Learned (Harrison's 22E, Section 9)
Chapter 65 - Interpreting Peripheral Blood Smears
How to systematically examine platelets → RBCs → WBCs using oil immersion. Every abnormal morphology (Auer rods, schistocytes, Howell-Jolly bodies, Pelger-Hüet, tear-drops, etc.) with its clinical meaning. RDW formula and its use in separating iron deficiency from thalassemia.
Chapter 66 - Anemia and Polycythemia
The three mechanisms of anemia (hypoproliferative, maturation defect, hemolysis/loss). EPO physiology. All iron studies with exact normal values. Megaloblastic vs microcytic workup. Myelophthisic (leukoerythroblastic) picture. Polycythemia vera vs secondary causes.
Chapter 67 - Disorders of Granulocytes and Monocytes
Neutrophil life cycle, killing mechanisms (oxidative burst, NETs). Neutropenia classification. Hereditary neutropenia syndromes (Kostmann, WHIM, Shwachman-Diamond, Felty). CGD, LAD, Chediak-Higashi. Eosinophilia and basophilia differentials.
Chapter 68 - Primary and Secondary HLH
HLH as hyperinflammatory convergent phenotype. Primary (genetic - perforin/PRF1 most common) vs secondary (EBV, T-cell lymphoma, MAS). HLH-2004 diagnostic criteria (5/8). Ferritin >10,000 = red flag. Treatment with dexamethasone + etoposide + HSCT for primary.
Chapter 69 - Bleeding and Thrombosis
Mucosal bleeding = platelet/VWD vs hemarthroses = factor deficiency. Primary hemostasis defects (VWD, Bernard-Soulier, Glanzmann's). Coagulation cascade and what each test (PT, aPTT) measures. Inherited thrombophilias (Factor V Leiden most common). APS paradox (prolonged aPTT but causes clots).
Chapter 70 - Lymph Node and Spleen Enlargement
Lymphadenopathy approach: <1% malignancy in primary care. Supraclavicular node = always investigate. When to biopsy. Massive splenomegaly differentials. Hypersplenism. Asplenic patient vaccination.